The DOI matches its Crossref record; 117 of the 117 references it cites were found in a registry or an index.
MIF: a new cytokine link between rheumatoid arthritis and atherosclerosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
Inflammation in atherosclerosis
Libby, P. (2002) · Nature · doi:10.1038/nature01323 · Cited by 8,315
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541
Sapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
Lusis, A. J. (2000) · Nature · doi:10.1038/35025203 · Cited by 4,839
Physiological functions of glucocorticoids in stress and their relation to pharmacological actions
MUNCK, A., GUYRE, P. M., & HOLBROOK, N. J. (1984) · Endocrine Reviews · doi:10.1210/edrv-5-1-25 · Cited by 3,083
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., & Karin, M. (1995) · Science · doi:10.1126/science.270.5234.286 · Cited by 2,390
Anti-inflammatory Actions of Glucocorticoids: Molecular Mechanisms
Barnes, P. J. (1998) · Clinical Science · doi:10.1042/cs0940557 · Cited by 1,591
Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus
Roman, M. J., Shanker, B.-A., Davis, A., Lockshin, M. D., Sammaritano, L., Simantov, R., Crow, M. K., Schwartz, J. E., Paget, S. A., Devereux, R. B., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035471 · Cited by 1,427
Statin Therapy, LDL Cholesterol, C-Reactive Protein, and Coronary Artery Disease
Nissen, S. E., Tuzcu, E. M., Schoenhagen, P., Crowe, T., Sasiela, W. J., Tsai, J., Orazem, J., Magorien, R. D., O'Shaughnessy, C., & Ganz, P. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042000 · Cited by 1,325
David, J. R. (1966) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.56.1.72 · Cited by 1,273
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition
Genovese, M. C., Becker, J.-C., Schiff, M., Luggen, M., Sherrer, Y., Kremer, J., Birbara, C., Box, J., Natarajan, K., Nuamah, I., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050524 · Cited by 1,241
MIF Signal Transduction Initiated by Binding to CD74
Leng, L., Metz, C. N., Fang, Y., Xu, J., Donnelly, S., Baugh, J., Delohery, T., Chen, Y., Mitchell, R. A., & Bucala, R. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030286 · Cited by 1,154
MIF as a glucocorticoid-induced modulator of cytokine production
Calandra, T., Bernhagen, J., Metz, C. N., Spiegel, L. A., Bacher, M., Donnelly, T., Cerami, A., & Bucala, R. (1995) · Nature · doi:10.1038/377068a0 · Cited by 1,149
Self-citationThomson, A. W. (1994) · Cited by 1,116
Innate and Adaptive Immunity in the Pathogenesis of Atherosclerosis
Hansson, G. K., Libby, P., Schönbeck, U., & Yan, Z.-Q. (2002) · Circulation Research · doi:10.1161/01.res.0000029784.15893.10 · Cited by 1,024
MIF is a pituitary-derived cytokine that potentiates lethal endotoxaemia
Bernhagen, J., Calandra, T., Mitchell, R. A., Martin, S. B., Tracey, K. J., Voelter, W., Manogue, K. R., Cerami, A., & Bucala, R. (1993) · Nature · doi:10.1038/365756a0 · Cited by 999
Self-citationCalandra, T., Bernhagen, J., Mitchell, R. A., & Bucala, R. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.6.1895 · Cited by 985
Self-citationTherapeutic strategies for rheumatoid arthritis
Smolen, J. S., & Steiner, G. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1109 · Cited by 911
Premature Coronary-Artery Atherosclerosis in Systemic Lupus Erythematosus
Asanuma, Y., Oeser, A., Shintani, A. K., Turner, E., Olsen, N., Fazio, S., Linton, M. F., Raggi, P., & Stein, C. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035611 · Cited by 892
Ip, J. H., Fuster, V., Badimon, L., Badimon, J., Taubman, M. B., & Chesebro, J. H. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)92845-s · Cited by 765
Protection from septic shock by neutralization of macrophage migration inhibitory factor
Calandra, T., Echtenacher, B., Roy, D. L., Pugin, J., Metz, C. N., Hültner, L., Heumann, D., Männel, D., Bucala, R., & Glauser, M. P. (2000) · Nature Medicine · doi:10.1038/72262 · Cited by 723
Enhancing versus suppressive effects of stress hormones on skin immune function
Dhabhar, F. S., & McEwen, B. S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.3.1059 · Cited by 673
An essential regulatory role for macrophage migration inhibitory factor in T-cell activation.
Bacher, M., Metz, C. N., Calandra, T., Mayer, K., Chesney, J., Lohoff, M., Gemsa, D., Donnelly, T., & Bucala, R. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7849 · Cited by 664
A Proinflammatory Cytokine Inhibits P53 Tumor Suppressor Activity
Hudson, J. D., Shoaibi, M. A., Maestro, R., Carnero, A., Hannon, G. J., & Beach, D. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.10.1375 · Cited by 649
Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P. J., & Adcock, I. M. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20050466 · Cited by 638
Mitchell, R. A., Liao, H., Chesney, J., Fingerle-Rowson, G., Baugh, J., David, J., & Bucala, R. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.012511599 · Cited by 622
Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells
Galon, J., Franchimont, D., Hiroi, N., Frey, G., Boettner, A., Ehrhart-Bornstein, M., O’shea, J. J., Chrousos, G. P., & Bornstein, S. R. (2002) · The FASEB Journal · doi:10.1096/fj.01-0245com · Cited by 606
Accelerated atherosclerosis: An extraarticular feature of rheumatoid arthritis?
Van Doornum, S., McColl, G., & Wicks, I. P. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10089 · Cited by 606
MIF regulates innate immune responses through modulation of Toll-like receptor 4
Roger, T., David, J., Glauser, M. P., & Calandra, T. (2001) · Nature · doi:10.1038/414920a · Cited by 584
Anti-TNF-α therapies: the next generation
Palladino, M. A., Bahjat, F. R., Theodorakis, E. A., & Moldawer, L. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1175 · Cited by 576
Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1
Kleemann, R., Hausser, A., Geiger, G., Mischke, R., Burger-Kentischer, A., Flieger, O., Johannes, F.-J., Roger, T., Calandra, T., Kapurniotu, A., et al. (2000) · Nature · doi:10.1038/35041591 · Cited by 568
Self-citationColao, A. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.8.2664 · Cited by 450
Mitchell, R. A., Metz, C. N., Peng, T., & Bucala, R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.18100 · Cited by 448
Walsh, L. J., Wong, C. A., Pringle, M., & Tattersfield, A. E. (1996) · BMJ · doi:10.1136/bmj.313.7053.344 · Cited by 383
Hermanowski-Vosatka, A., Balkovec, J. M., Cheng, K., Chen, H. Y., Hernandez, M., Koo, G. C., Le Grand, C. B., Li, Z., Metzger, J. M., Mundt, S. S., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050119 · Cited by 364
Baugh, J. A., Chitnis, S., Donnelly, S. C., Monteiro, J., Lin, X., Plant, B. J., Wolfe, F., Gregersen, P. K., & Bucala, R. (2002) · Genes & Immunity · doi:10.1038/sj.gene.6363867 · Cited by 360
Faggiano, A., Pivonello, R., Spiezia, S., De Martino, M. C., Filippella, M., Di Somma, C., Lombardi, G., & Colao, A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021558 · Cited by 358
Rosengren, E., Bucala, R., Åman, P., Jacobsson, L., Odh, G., Metz, C. N., & Rorsman, H. (1996) · Molecular Medicine · doi:10.1007/bf03402210 · Cited by 350
Kleemann, R., Kapurniotu, A., Frank, R. W., Gessner, A., Mischke, R., Flieger, O., Jüttner, S., Brunner, H., & Bernhagen, J. (1998) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.1864 · Cited by 311
Self-citationLeech, M., Metz, C., Hall, P., Hutchinson, P., Gianis, K., Smith, M., Weedon, H., Holdsworth, S. R., Bucala, R., & Morand, E. F. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199908)42:8<1601::aid-anr6>3.0.co;2-b · Cited by 311
Self-citationAl-Abed, Y., Dabideen, D., Aljabari, B., Valster, A., Messmer, D., Ochani, M., Tanovic, M., Ochani, K., Bacher, M., Nicoletti, F., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.c500243200 · Cited by 307
Lubetsky, J. B., Dios, A., Han, J., Aljabari, B., Ruzsicska, B., Mitchell, R., Lolis, E., & Al-Abed, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203220200 · Cited by 304
Chesney, J., Metz, C., Bacher, M., Peng, T., Meinhardt, A., & Bucala, R. (1999) · Molecular Medicine · doi:10.1007/bf03402061 · Cited by 284
Expression of Macrophage Migration Inhibitory Factor in Different Stages of Human Atherosclerosis
Burger-Kentischer, A., Goebel, H., Seiler, R., Fraedrich, G., Schaefer, H. E., Dimmeler, S., Kleemann, R., Bernhagen, J., & Ihling, C. (2002) · Circulation · doi:10.1161/01.cir.0000012942.49244.82 · Cited by 259
Self-citationMikulowska, A., Metz, C. N., Bucala, R., & Holmdahl, R. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.11.5514 · Cited by 258
The macrophage migration inhibitory factor MIF is a phenylpyruvate tautomerase
Rosengren, E., Åman, P., Thelin, S., Hansson, C., Ahlfors, S., Björk, P., Jacobsson, L., & Rorsman, H. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01261-1 · Cited by 257
Onodera, S., Kaneda, K., Mizue, Y., Koyama, Y., Fujinaga, M., & Nishihira, J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.444 · Cited by 253
Bernhagen, J., Bacher, M., Calandra, T., Metz, C. N., Doty, S. B., Donnelly, T., & Bucala, R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.1.277 · Cited by 253
Self-citationTargeting IL-1 in inflammatory disease: new opportunities for therapeutic intervention
Braddock, M., & Quinn, A. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1342 · Cited by 214
Lue, H., Kapurniotu, A., Fingerle-Rowson, G., Roger, T., Leng, L., Thiele, M., Calandra, T., Bucala, R., & Bernhagen, J. (2006) · Cellular Signalling · doi:10.1016/j.cellsig.2005.06.013 · Cited by 209
Self-citationRadstake, T. R. D. J., Sweep, F. C. G. J., Welsing, P., Franke, B., Vermeulen, S. H. H. M., Geurts‐Moespot, A., Calandra, T., Donn, R., & van Riel, P. L. C. M. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21285 · Cited by 209
Swope, M. (1998) · The EMBO Journal · doi:10.1093/emboj/17.13.3534 · Cited by 204
Roger, T., Chanson, A., Knaup‐Reymond, M., & Calandra, T. (2005) · European Journal of Immunology · doi:10.1002/eji.200535413 · Cited by 184
Mercer, J., Figg, N., Stoneman, V., Braganza, D., & Bennett, M. R. (2005) · Circulation Research · doi:10.1161/01.res.0000161069.15577.ca · Cited by 181
JAB1/CSN5 and the COP9 signalosome: A complex situation
Chamovitz, D. A., & Segal, D. (2001) · EMBO reports · doi:10.1093/embo-reports/kve028 · Cited by 179
The Metabolic Syndrome and Cardiovascular Risk in Cushing's Syndrome
Pivonello, R., Faggiano, A., Lombardi, G., & Colao, A. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.010 · Cited by 173
Modulation of inflammation and response to dexamethasone by Annexin 1 in antigen‐induced arthritis
Yang, Y. H., Morand, E. F., Getting, S. J., Paul‐Clark, M., Liu, D. L., Yona, S., Hannon, R., Buckingham, J. C., Perretti, M., & Flower, R. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20201 · Cited by 173
Self-citationSchober, A., Bernhagen, J., Thiele, M., Zeiffer, U., Knarren, S., Roller, M., Bucala, R., & Weber, C. (2004) · Circulation · doi:10.1161/01.cir.0000109201.72441.09 · Cited by 171
Self-citationPan, J.-H., Sukhova, G. K., Yang, J.-T., Wang, B., Xie, T., Fu, H., Zhang, Y., Satoskar, A. R., David, J. R., Metz, C. N., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134704.84454.d2 · Cited by 169
Senter, P. D., Al-Abed, Y., Metz, C. N., Benigni, F., Mitchell, R. A., Chesney, J., Han, J., Gartner, C. G., Nelson, S. D., Todaro, G. J., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.011569399 · Cited by 166
Onodera, S., Nishihira, J., Iwabuchi, K., Koyama, Y., Yoshida, K., Tanaka, S., & Minami, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106020200 · Cited by 165
Lubetsky, J. B., Swope, M., Dealwis, C., Blake, P., & Lolis, E. (1999) · Biochemistry · doi:10.1021/bi990306m · Cited by 163
Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis
Leech, M. T., Metz, C. N., Santos, L. L., Peng, T., Holdsworth, S. R., Bucala, R., & Morand, E. F. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199805)41:5<910::aid-art19>3.0.co;2-e · Cited by 158
Self-citationBendrat, K., Al‐Abed, Y., Callaway, D. J. E., Peng, T., Calandra, T., Metz, C. N., & Bucala, R. (1997) · Biochemistry · doi:10.1021/bi971153a · Cited by 156
Oxidized LDL Stimulates Mitogen-Activated Protein Kinases in Smooth Muscle Cells and Macrophages
Kusuhara, M., Chait, A., Cader, A. A., & Berk, B. C. (1997) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.17.1.141 · Cited by 151
The use of TNF-? blocking agents in rheumatoid arthritis: an overview
Toussirot, É., & Wendling, D. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.3.581 · Cited by 145
Trichostatin A Exacerbates Atherosclerosis in Low Density Lipoprotein Receptor–Deficient Mice
Choi, J., Nam, K., Kim, J.-Y., Baek, M. W., Park, J.-E., Park, H., Kwon, H. J., Kwon, O., Kim, D.-Y., & Oh, G. T. (2005) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000184758.07257.88 · Cited by 143
Santos, L. L., Hall, P., Metz, C. N., Bucala, R., & Morand, E. F. (2001) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2001.01423.x · Cited by 138
Self-citationThe Cytokine Macrophage Migration Inhibitory Factor Reduces Pro-Oxidative Stress-Induced Apoptosis
Nguyen, M. T., Lue, H., Kleemann, R., Thiele, M., Tolle, G., Finkelmeier, D., Wagner, E., Braun, A. B., & Bernhagen, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.6.3337 · Cited by 137
Self-citationBurger‐Kentischer, A., Göbel, H., Kleemann, R., Zernecke, A., Bucala, R., Leng, L., Finkelmeier, D., Geiger, G., Schaefer, H. E., Schober, A., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.03.028 · Cited by 132
Self-citationMacrophage migration inhibitory factor in systemic lupus erythematosus.
Foote, A., Briganti, E. M., Kipen, Y., Santos, L., Leech, M. T., & Morand, E. F. (2004) · PubMed · Cited by 132
Self-citationDe Novo Expression of Macrophage Migration Inhibitory Factor in Atherogenesis in Rabbits
Shu-guang, L., Yu, X., Chen, Y., Huang, X. R., Metz, C. N., Bucala, R., Lau, C., & Lan, H. Y. (2000) · Circulation Research · doi:10.1161/01.res.87.12.1202 · Cited by 129
Dios, A., Mitchell, R. A., Aljabari, B., Lubetsky, J. B., O'Connor, K., Liao, H., Senter, P. D., Manogue, K. R., Lolis, E., Metz, C. N., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm010534q · Cited by 124
Macrophage migration inhibitory factor in rheumatoid arthritis: clinical correlations
Morand, E. F. (2002) · British journal of rheumatology · doi:10.1093/rheumatology/41.5.558 · Cited by 122
Self-citationCritical Role of Macrophage Migration Inhibitory Factor Activity in Experimental Autoimmune Diabetes
Cvetković, I., Al‐Abed, Y., Miljković, D. M., Maksimović‐Ivanić, D., Roth, J., Bacher, M., Lan, H. Y., Nicoletti, F., & Stošić‐Grujičić, S. (2005) · Endocrinology · doi:10.1210/en.2004-1393 · Cited by 116
Macrophage migration inhibitory factor is a critical mediator of severe acute pancreatitis
Sakai, Y., Masamune, A., Satoh, A., et al. (2003) · Gastroenterology · doi:10.1053/gast.2003.50099 · Cited by 116
Regulation of p53 by macrophage migration inhibitory factor in inflammatory arthritis
Leech, M. T., Lacey, D. C., Xue, J. R., Santos, L. L., Hutchinson, P. E., Wolvetang, E. J., David, J. R., Bucala, R., & Morand, E. F. (2003) · Arthritis & Rheumatism · doi:10.1002/art.11165 · Cited by 114
Self-citationControl of fibroblast‐like synoviocyte proliferation by macrophage migration inhibitory factor
Lacey, D. C., Sampey, A. V., Mitchell, R. A., Bucala, R., Santos, L., Leech, M. T., & Morand, E. F. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10733 · Cited by 111
Self-citationHermanowski‐Vosatka, A., Mundt, S. S., Ayala, J. M., Goyal, S., Hanlon, W. A., Czerwiński, R., Wright, S. D., & Whitman, C. P. (1999) · Biochemistry · doi:10.1021/bi991352p · Cited by 109
Meyer‐Siegler, K. L., Leifheit, E. C., & Vera, P. L. (2004) · BMC Cancer · doi:10.1186/1471-2407-4-34 · Cited by 108
Aeberli, D., Yang, Y. H., Mansell, A. S., Santos, L., Leech, M. T., & Morand, E. F. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.01.027 · Cited by 108
Self-citationSampey, A. V., Hall, P., Mitchell, R. A., Metz, C. N., & Morand, E. F. (2001) · Arthritis & Rheumatism · Cited by 105
Self-citationLink Between Macrophage Migration Inhibitory Factor and Cellular Redox Regulation
Thiele, M., & Bernhagen, J. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1234 · Cited by 102
Self-citationJung, H., Kim, T., Chae, H. Z., Kim, K., & Ha, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m009620200 · Cited by 99
Structure of a trimeric domain of the MHC class II‐associated chaperonin and targeting protein Ii
Jasanoff, A., Wagner, G. H., & Wiley, D. C. (1998) · The EMBO Journal · doi:10.1093/emboj/17.23.6812 · Cited by 95
Leech, M. T., Metz, C. N., Bucala, R., & Morand, E. F. (2000) · Arthritis & Rheumatism · Cited by 92
Self-citationOnodera, S., Nishihira, J., Koyama, Y., Majima, T., Aoki, Y., Ichiyama, H., Ishibashi, T., & Minami, A. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20190 · Cited by 92
Macrophage Migration Inhibitory Factor Gene Polymorphism is Associated with Psoriasis
Donn, R. P., Plant, D., Jury, F., Richards, H. L., Worthington, J., Ray, D., & Griffiths, C. E. M. (2004) · Journal of Investigative Dermatology · doi:10.1111/j.0022-202x.2004.23314.x · Cited by 92
Macrophage Migration Inhibitory Factor MIF Interferes with the Rb-E2F Pathway
Petrenko, O., & Moll, U. M. (2005) · Molecular Cell · doi:10.1016/j.molcel.2004.11.052 · Cited by 90
Evidence for a Role of Macrophage Migration Inhibitory Factor in Vascular Disease
Chen, Z., Sakuma, M., Zago, A. C., Zhang, X., Shi, C., Leng, L., Mizue, Y., Bucala, R., & Simon, D. I. (2004) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000119356.35748.9e · Cited by 89
Gregory, J. L., Leech, M. T., David, J. R., Yang, Y. H., Dacumos, A., & Hickey, M. J. (2004) · Arthritis & Rheumatism · doi:10.1002/art.20470 · Cited by 89
Self-citationNguyen, M. T., Beck, J., Lue, H., Fünfzig, H., Kleemann, R., Koolwijk, P., Kapurniotu, A., & Bernhagen, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301735200 · Cited by 84
Self-citationKong, Y.-Z., Yu, X., Tang, J.-J., Ouyang, X., Huang, X.-R., Fingerle‐Rowson, G., Bacher, M., Scher, L. A., Bucala, R., & Lan, H. Y. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.08.030 · Cited by 84
Nohara, H., Okayama, N., Inoue, N., Koike, Y., Fujimura, K., Suehiro, Y., Hamanaka, Y., Higaki, S., Yanai, H., Yoshida, T., et al. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-003-1284-7 · Cited by 83
Swant, J. D., Rendon, B. E., Symons, M. H., & Mitchell, R. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500636200 · Cited by 78
Mechanisms of Monocyte Recruitment in Vascular Repair After Injury
Schober, A., & Weber, C. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1249 · Cited by 74
Taylor, A. B., Johnson, W. H., Czerwiński, R., Li, H.-S., Hackert, M. L., & Whitman, C. P. (1999) · Biochemistry · doi:10.1021/bi9904048 · Cited by 73
Petrenko, O., Fingerle‐Rowson, G., Peng, T., Mitchell, R. A., & Metz, C. N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211985200 · Cited by 72
Macrophage migration inhibitory factor is associated with aneurysmal expansion
Pan, J., Lindholt, J. S., Sukhova, G. K., et al. (2003) · Journal of Vascular Surgery · doi:10.1067/mva.2003.74 · Cited by 68
Кirilov, G., Tomova, A., Dakovska, L., Kumanov, P., Shinkov, A. D., & Alexandrov, A. (2003) · European Journal of Endocrinology · doi:10.1530/eje.0.1490549 · Cited by 67
Kleemann, R., Kapurniotu, A., Mischke, R., Held, J., & Bernhagen, J. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00327.x · Cited by 60
Self-citationMacrophage Migration Inhibitory Factor and the Discovery of Tautomerase Inhibitors
Orita, M., Yamamoto, S., Katayama, N., & Fujita, S. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612023394674 · Cited by 59
Tumour necrosis factor α as a therapeutic target for immune-mediated inflammatory diseases
Taylor, P. C., Williams, R. O., & Feldmann, M. (2004) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2004.09.005 · Cited by 57
Regulation of arthritis by p53: Critical role of adaptive immunity
Šimelyte, E., Rosengren, S., Boyle, D. L., et al. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21099 · Cited by 57
KONG, Y., HUANG, X., OUYANG, X., TAN, J., Fingerle‐Rowson, G., Bacher, M., MU, W., Scher, L. A., Leng, L., & Bucala, R. (2004) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.09.020 · Cited by 52
Re-examining the oligomerization state of macrophage migration inhibitory factor (MIF) in solution
Philo, J. S., Yang, T., & LaBarre, M. J. (2004) · Biophysical Chemistry · doi:10.1016/j.bpc.2003.10.010 · Cited by 50
Cortisol in urine and saliva: relations to the intima media thickness, IMT
Eller, N. H., Netterstrøm, B., & Hansen, Å. M. (2001) · Atherosclerosis · doi:10.1016/s0021-9150(01)00487-7 · Cited by 49
Verschuren, L., Lindeman, J. H. N., van Bockel, J. H., Abdul-Hussien, H., Kooistra, T., & Kleemann, R. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1195 · Cited by 48
Wadgaonkar, R., Dudek, S. M., Zaiman, A., Linz-McGillem, L. A., Verin, A. D., Nurmukhambetova, S. T., Romer, L. H., & Garcia, J. G. N. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20472 · Cited by 35
Atsumi, T., Nishihira, J., Makita, Z., & Koike, T. (2000) · Cytokine · doi:10.1006/cyto.2000.0745 · Cited by 22
Zhuang, S., Zou, J., Jiang, Y., Mao, X., Zhang, B., Liu, H., & Yu, Q. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050562z · Cited by 17
Therapeutic opportunities for antagonism of macrophage migration inhibitory factor
Morand, E. F., Leech, M. T., & Iskander, M. N. (2003) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.13.8.1189 · Cited by 3
Self-citationKomuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
Cytokines in the pathogenesis of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2007) · Nature Reviews Immunology · doi:10.1038/nri2094 · Cited by 2,529
Bernhagen, J., Krohn, R., Lue, H., Gregory, J. L., Zernecke, A., Koenen, R. R., Dewor, M., Georgiev, I., Schober, A., Leng, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1567 · Cited by 1,269
Self-citationEfficient Drug Lead Discovery and Optimization
Jorgensen, W. L. (2009) · Accounts of Chemical Research · doi:10.1021/ar800236t · Cited by 649
Monolayer coated gold nanoparticles for delivery applications
Rana, S., Bajaj, A., Mout, R., & Rotello, V. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.08.006 · Cited by 479
Lue, H., Thiele, M., Franz, J., Dahl, E., Speckgens, S., Leng, L., Fingerle-Rowson, G., Bucala, R., Lüscher, B., & Bernhagen, J. (2007) · Oncogene · doi:10.1038/sj.onc.1210318 · Cited by 385
Self-citation
Metadata
- Authors
- Morand, E. F., Leech, M., & Bernhagen, J.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2006-04-21
- Volume
- 5
- Issue
- 5
- Pages
- 399-411
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W2067583186
- Cited by
- 351
- References
- 117
- FWCI
- 1.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.